OQROGet OQRO Pro
Insider trade

Boston Scientific (BSX)Officer sold ~$750K

Emily Woodworth, Officer at Boston Scientific, sold ~$750K of Boston Scientific shares.

~$750K
Approx. value · 7,149 sh @ $104.97
914
Holds after · shares reported
Traded
Mar 3, 2025
Filed
Mar 5, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Dec 3, 2024InsiderOfficer purchased ~$4.5K of BSX shares in the open market
  2. Dec 10, 2024InsiderOfficer sold ~$1.8K of BSX shares in the open market
  3. Jan 2, 2025InsiderOfficer sold ~$371K of BSX shares in the open market
  4. Jan 3, 2025Insider · 3 peopleInsiders: 3 sales (~$1.7M)
  5. Feb 3, 2025Insider · 1 personInsiders: 2 sales (~$1.8M)
  6. Feb 7, 2025InsiderOfficer sold ~$685K of BSX shares in the open market
  7. Feb 11, 2025InsiderDirector sold ~$1.27M of BSX shares in the open market
  8. Feb 12, 2025Insider · 3 peopleInsiders: 3 sales (~$3.6M)
  9. Feb 13, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  10. Feb 14, 2025InsiderOfficer sold ~$128K of BSX shares in the open market
  11. Feb 18, 2025Insider · 2 peopleInsiders: 3 sales (~$2.1M)
  12. Feb 19, 2025Insider · 3 peopleInsiders: 3 sales (~$7.6M)
  13. Feb 21, 2025InsiderOfficer sold ~$505K of BSX shares in the open market
  14. Feb 24, 2025Insider · 2 peopleInsiders: 2 sales (~$1.9M)
  15. Feb 24, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  16. Feb 25, 2025InsiderOfficer sold ~$280K of BSX shares in the open market
  17. Feb 28, 2025InsiderOfficer sold ~$1M of BSX shares in the open market
  18. Mar 3, 2025 · this disclosureInsiderOfficer sold ~$750K of BSX shares in the open market

What came next

  1. Mar 3, 2025CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  2. Mar 4, 2025InsiderOfficer sold ~$50K of BSX shares in the open market
  3. Mar 17, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  4. Mar 21, 2025FDAFDA device clearance: Navigator™ HD Ureteral Access Sheath Set 11/13 F x 28cm (M0062502210); Navigator™ HD Ureteral Access Sheath Set 11/13 F x 36cm (M0062502220); Navigator™ HD Ure…
  5. Mar 21, 2025InsiderOfficer sold ~$487K of BSX shares in the open market
  6. Mar 24, 2025FDARecall: IceSeed 1.5 CX S NEEDLE OUS, Cryoablation Needle, REF H7493967334100. The needles are intended to convert high-pressure gas to either a very cold Freezing appl…
  7. Mar 24, 2025FDARecall: IceSeed 1.5 CX NEEDLE OUS, Cryoablation Needle, REF H7493967534170. The needles are intended to convert high-pressure gas to either a very cold Freezing applic…
  8. Mar 24, 2025FDARecall: IceSeed 1.5 CX S NEEDLE US, Cryoablation Needle, REF H7493967233100. The needles are intended to convert high-pressure gas to either a very cold Freezing appli…
  9. Mar 24, 2025FDARecall: IceSeed 1.5 CX NEEDLE US, Cryoablation Needle, REF H7493967433170. The needles are intended to convert high-pressure gas to either a very cold Freezing applica…
  10. Apr 1, 2025InsiderCEO sold ~$16.4M of BSX shares in the open market
  11. Apr 15, 2025FDAFDA device clearance: Percuflex Ureteral Stent; Percuflex Plus Ureteral Stent; Percuflex Plus SureDrive Steerable Ureteral Stent Set; Contour Ureteral Stent; Contour SureDrive Steer…
  12. Apr 21, 2025InsiderOfficer sold ~$459K of BSX shares in the open market
  13. Apr 21, 2025CongressDisclosed sale of BSX — reported range $1,001 - $15,000
  14. Apr 28, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  15. May 1, 2025Insider · 2 peopleInsiders: 3 sales (~$18.6M)
  16. May 5, 2025InsiderOfficer sold ~$478K of BSX shares in the open market
  17. May 12, 2025CongressDisclosed sale of BSX — reported range $15,001 - $50,000
  18. May 13, 2025CongressDisclosed partial sale of BSX — reported range $1,001 - $15,000
  19. May 21, 2025InsiderOfficer sold ~$514K of BSX shares in the open market
  20. May 28, 2025FDAFDA device clearance: OptiMap™ System
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Boston Scientific

For Boston Scientific, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 9 Congress trade reports, 64 fund holdings reports (13F) and 8 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.

Other recent filings by Emily Woodworth, SVP, Global Controller and CAO

The full history of Emily Woodworth, SVP, Global Controller and CAO is on the profile page.

How this filing works

Other disclosures at Boston Scientific

Everything OQRO holds on this company is on its BSX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data